Bio-Rad Authorizes New $250 Million Share Repurchase Program
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Oil drops more than $2 despite new US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- Grand Canyon Education places CFO on leave amid stock trade probe
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Funds sell $44bn in semiconductors on AI concerns
- RUM Group signs $13.7 billion GPU services deal, issues warrants
Bio-Rad Labs (BIO) PT Raised to $290 at CL King
November 29, 2017 7:39 AM ESTCL King raised its price target on Bio-Rad Labs (NYSE: BIO) to $290.00 while maintaining a Buy rating.
Analyst David Westenberg said operating margin targets look reasonable.
... More